Poly(A) is found on the 3-OH terminus of many cellular and viral RNA molecules (1, 9, 11, 12, 14, 16, 18, 19, 20, 24, 26, 30, 31) . Most studies suggest that the poly(A) is not transcribed from a DNA template (5, 8, 24, 30) . Poly(A) polymerases are not dependent on a DNA template but are dependent on either poly(A), oligo(A), or RNA for the incorporation of ATP into poly(A). The synthesis of poly(A) by enzymes from calf thymus nuclei (10) and from ascites cells (15, 17) is stimulated by poly(A). Terminal transferases from calf thymus (29) and vaccinia virus (6) are stimulated by oligoriboadenylate. Little evidence is available that these enzymes are capable of adding poly(A) to messenger-like RNA molecules in vivo.
Vaccinia virions synthesize poly(A) and RNA in vitro (18, 19) . The poly(A) is associated with RNA (19) . Moss et al. (22) have recently purified the poly(A) polymerase from the vaccinia virion. Although stimulation of poly(A) synthesis by poly(dA)-poly(dT) and by poly(rC) was observed, it was not demonstrated that the isolated enzyme was capable of adding poly(A) to vaccinia virus mRNA.
The preceding paper (5) describes the properties of a poly(A) polymerase induced in the cytoplasm of vaccinia virus-infected HeLa cells. I That report shows that poly(A) synthesis is dependent on either intact RNA associated with the partially purified enzyme or on added poly(U). To further show that this enzyme is able to add poly(A) to messenger-like RNA, the present study was undertaken to characterize the product of the in vitro enzyme reaction. It is shown here that AMP residues are added to the 3'-OH terminus of the endogenous vaccinia virus RNA. Although most of the endogenous RNA contains poly(A), incubation of the enzyme-RNA complex with ATP results in the addition of AMP to nucleosides other than AMP, suggesting that this enzyme is capable of adding poly(A) to RNA which does not contain a poly(A) chain. Poly(U) also serves as a primer for poly(A) synthesis.
MATERIALS AND METHODS
Virus, infection procedures, and in vitro enzyme assay. Virus preparation and experimental infection procedures are described in the preceding report as are the procedures for enzyme preparation and reaction conditions (5) .
After termination of the in vitro incubations by addition of EDTA to 0.01 M and sarkosyl (Geigy) to 0.5%, the product was purified by CHClI:phenol extraction and precipitation from ethanol. In order that the "ytoplasmic label be primarily in vaccinia virus-specific RNA, labeling of infected cells was allowed to proceed for only 15 min (3, 19) .
After labeling, cultures were harvested and treated as described (5) . High-speed centrifugation, ammonium sulfate fractionation, and agarose chromatography were performed on the cytoplasmic fractions from uninfected and infected cells (5; see Table 1 ). Portions of the eluate from the agarose column were tested for 3H-label and for poly(A) polymerase activity. Only the preparation from infected cells contained fractions active in poly(A) synthesis. The active fractions and comparable fractions of the preparation from uninfected cells were pooled separatelv.
Polyacrylamide gel electrophoresis of RNA. Polyacrylamide gels (2.5%), 9 cm in length, were prepared and run as described by Loening (21 Sucrose density gradient analysis of RNA. Labeled "enzyme" preparations and reaction mixtures were treated with sarkosyl (0.5%) and analyzed on 5 to 20% (wt/vol) sucrose gradients in 0.01 M Tris-hydrochloride, pH 7.5, 0.1 M NaCl, 0.005 M EDTA, 0.2% sarkosyl. Centrifugation was carried out at 20 C, 39,000 rpm in the SW 41 rotor for the times indicated in the individual experiments. To suppress degradation of poly(A) by pancreatic RNase, the gradients in Fig. 5 were prepared in 0.2 M NaCl (4). HeLa cell rRNA was run in parallel gradients as a standard. Fractions (0.5 ml each) were collected and acidinsoluble label was determined.
Polynucleotide phosphorylase phosphorolysis of RNA. Polynucleotide phosphorylase (P. L. Biochemicals) was used exactly as described by Sheldon et al. (27) . RNA for analysis was prepared by phenol:CHCl3 (1:1) extraction, ethanol precipitation, and LiCl precipitation (2) followed by desalting on Sephadex G-25.
RESULTS
Properties of the in vitro product. During infection of HeLa cells vaccinia virus induces an enzyme which, in vitro, catalyzes the incorporation of ATP into acid-insoluble material (5) . The product of the reaction was tested for nuclease sensitivity ( 2). These results show that ATP is polymerized into poly(A) by the enzyme preparation described in the preceding paper (5) . Size of the in vitro product. To determine the size of the in vitro synthesized poly(A), the reaction product was purified and its mobility on polyacrylamide gels was compared to rRNA. The purification was performed with and without digestion with RNase to give an indication of the possible association of the in vitro synthesized poly(A) with RNase susceptible endogenous RNA (5) . A reaction mixture of substrates and enzyme was incubated for 60 min, at which time a portion was further incubated 30 min at 37 C in the presence of an excess of EDTA and high salt. The other portion was incubated further with EDTA, salt, and pancreatic RNase (5 gg/ml). The reaction mixtures were then treated with sarkosyl and purified as described in Materials and Methods. Analysis of the product on 2.5% polyacrylamide gels ( Fig. 1) shows that the RNase treatment caused more label to migrate as small RNA molecules. DNase had no effect on the migration of the product (unpublished observations). This result suggested that in vitro polymerized AMP residues were attached to RNase-sensitive species ranging in mobility from that of 5S rRNA to that of 28S rRNA.
Characteristics of endogenous RNA. The results shown in Fig. 1 and those described by Brakel and Kates (5) which co-purified with the poly(A) polymerase was necessary for enzyme activity and may become associated with the in vitro synthesized poly(A). To examine the characteristics of the RNA associated with the enzyme fraction, infected cells were labeled with [3Hluridine for 15 min as described in Materials and Methods. Enzyme was purified from the labeled cytoplasm. To examine the possibility that host DNA-like RNA might be found in a similar fraction, uninfected cells were labeled as described and a similar "enzyme" preparation was made. Uninfected cells were, however, labeled for a period of time (2 h The RNA was analyzed by sucrose density gradient centrifugation in the presence of sarkosyl. Figure 2 shows the distribution of labeled material after centrifugation. The RNA from the infected preparations (Fig. 2B ) shows a distribution similar to that of total rapidly labeled cytoplasmic RNA from vaccinia virus-infected cells (3, 19) . The RNA from uninfected cells was slowly sedimenting (Fig. 2A) .
The RNA co-purifying with the enzyme preparation was examined for its poly(A) content. A [3H]adenosine-labeled enzyme preparation from infected cells was analyzed on polyacrylamide gels with and without digestion with pancreatic RNase (Fig. 3) . The results show that there is RNase-resistant material that migrates as vaccinia poly(A) (from 4 to 12S) (27a). The RNA migrated between 18 and 28S rRNA prior to RNase digestion; its migration is similar to that of in vitro vaccina core RNA and in vivo vaccinia virus RNA. The apparent size discrepancy suggested by a comparison of its sedimentation in sucrose gradients (Fig. 2) and its migration in polyacrylamide gels (Fig. 3) has been routinely observed in our laboratory with vaccinia virus RNA (C. Brakel Figure 4 shows that the activity is distributed in two rapidly sedimenting peaks. A peak of in vivo synthesized, tritium label coincides with the more slowly sedimenting peak. There is little presynthesized RNA found outside regions of enzyme activity. The in vivo RNA sediments considerably faster under the native conditions of the glycerol gradient centrifugation than under the disruptive conditions employed during sucrose gradient centrifugation (Fig. 2) . The preparation from uninfected cells was analyzed similarly VOL. 14, 1974 on August 27, 2017 by guest http://jvi.asm.org/ Downloaded from and very little RNA was found to be rapidly sedimenting (Fig. 4B) . These results suggest that the vaccinia virus RNA isolated in the enzyme fraction is associated with a rapidly sedimenting complex containing poly(A) polymerase activity and that uninfected cells do not contain a similar complex.
Association of the in vitro product with endogenous RNA. The results shown in Fig. 1 [4] ) and sarkosyl and the distribution of radioactivity after centrifugation was determined (Fig. 5) The association of in vitro synthesized poly(A) with large RNA is substantiated by LiCl precipitation. Purified, double-labeled material from either the uridine-or adenosinelabeled enzyme is all precipitable with 2 M LiCl. If the poly(A) was not associated with large RNA and was smaller than 5 to 6S, as suggested by the results in Fig. 5 , it would not be LiCl precipitable (2) . That this is true is confirmed by the observation that poly(A) isolated by nuclease digestion of vaccinia virus RNA is not precipitable by 2 M LiCl (27a).
Three-prime terminal location of in vitro synthesized poly(A). Poly(A) is located on the 3-OH terminus of vaccinia virus RNA (27) . If the poly(A) polymerase is acting in vitro as it presumably does in vivo, the in vitro synthesized poly(A) should be 3' terminally located. To test this, RNA was prepared from a reaction of [3HJuridine-labeled enzyme preparation with ["C]ATP. The RNA was purified as described in Materials and Methods. The amount of acidinsoluble material was determined after incubation with polynucleotide phosphorylase under conditions which promote phosphorolysis (27) .
The '4C label is lost rapidly from the acidinsoluble fraction (Fig. 6) , whereas the 3H label is lost more slowly. RNA from unreacted [3H]uridine-labeled enzyme was treated similarly and is degraded similarly to the other tritium-labeled material. This result shows that the poly(A) synthesized in vitro is terminated by a 3-OH group. In combination with the above result, this indicates that poly(A) is synthesized on the 3-OH end of the endogenous RNA.
Polymerization of poly(A) on poly(U). The above results suggested that poly(A) is polymerized in vitro on the 3'-OH termini of endogenous RNA molecules. If poly(A) was, indeed, made on RNA primers, nearest neighbor analysis might show that phosphate is transferred from ATP to some nucleotide other than AMP.
Accordingly, poly(A) was synthesized from a 32P-labeled ATP. The product was hydrolyzed with alkali and the resultant 3' mononucleotides were separated by high voltage electrophoresis (25, 28 To show that poly(A) could be polymerized on added RNA, advantage was taken of the stimulation of overall incorporation by poly(U) (5) . Poly(U) was included in the a 32P-ATPlabeled reaction mixtures at 25,ug/ml and at 100 Mg/ml. The product was hydrolyzed with alkali and the incorporation of 32P into UMP residues was compared to reaction mixtures that did not contain added polynucleotide or which con-VOL. 14, 1974 on August 27, 2017 by guest http://jvi.asm.org/ Downloaded from h, substrates were added to each enzyme mixture; the first received no other additions, the second received poly(U), as did the third, and incorporation was allowed to proceed for 1 h. In all cases samples were processed by addition of unlabeled HeLa RNA to 100 ,ug/ml and were precipitated with 5% perchloric acid. Further treatment and separation of the resultant 3' mononucleotides were performed as described by Sebring (25) and Smith (28) .
tained poly(C) at 10 ,g/ml (the stimulatory concentration for that polynucleotide-see 5) . The results (Table 3 , experiments 1 and 2) show that the stimulation of incorporation by poly(U) is accountable in the increase in incorporation of 32P into AMP and UMP residues. The amount of labeled CMP and GMP residues was not increased. In the reaction with no added poly(U), 0.16 nmol of AMP was added to uridine ends. In the presence of 25 Mg of poly(U) per ml, 0.8 nmol of AMP was added to uridine ends, an increase of 0.64 nmol. Assuming a molecular weight of 5 x 104 for poly(U), this means that 1 nmol of poly(U) was added and could, therefore, account for all the increase in uridine ends used. No increase in the cytidine or uridine ends used is observed in reactions containing poly(C). This suggests that the effect of poly(U) was not a nonspecific effect of adding polynucleotides. Although poly(C) is slightly stimulatory at the concentration used, its effect is not due to its use as a primer for polymerization of AMP residues.
Since T, RNase treatment was capable of inhibiting all enzymatic activity in the absence of added poly(U) (5), we reasoned that treatment of the enzyme preparation with T, RNase might result in reduction of the use of endogenous RNA primers. This effect was observed with preparations which were either pretreated with T, RNase or were treated with T, RNase during the reaction with ATP and added poly(U) ( Table 3 , experiment 3). Addition of T, RNase and poly(U) at the time of substrate addition resulted in considerable diminufion of the use of cytosine and guanosine ends. Pretreatment with T, RNase further reduced the number of cytosine ends which were used. In both cases, the number of uridine ends used increased to an extent accountable by the number of added uridine ends.
DISCUSSION
The product of the in vitro reaction of ATP with an enzyme induced in HeLa cells by vaccinia virus infection is poly(A) ( Table 1 ). The product is resistant to RNase and DNase, is susceptible to alkali and is able to bind to poly(U). Polyacrylamide gel electrophoresis of the product purified with and without RNase digestion shows that in vitro synthesized poly(A) is associated with RNase-sensitive material. The preceding report (5) suggested that endogenous RNA, co-purifying with poly(A) polymerase activity, participates in the ATP polymerization. This RNA was characterized. The RNA sediments similarly to vaccinia virus in vitro core or total in vivo vaccinia virus RNA (19) , contains poly(A) which migrates on polyacrylamide gels between 5 and llS, and is able to bind to poly(U) filters with high efficiency. These results indicate that the poly(A) polymerase may be associated, within the cell, with mRNA on which poly(A) is being polymerized. Glycerol gradient centrifugation of the enzyme-RNA complex shows that the RNA and enzymatic activity co-sediment. Under these conditions little RNA sediments in regions devoid of enzymatic activity (Fig. 4) . Comparable preparations from uninfected cells contain a small amount of labeled RNA but are completely devoid of poly(A) polymerase activity and are devoid of protein which is able to cause the RNA to sediment rapidly under the conditions of glycerol gradient centrifugation. These results suggest that in the infected cells there may be a complex between RNA and a poly(A) polymerase. This complex is free of RNA polymerase activity (see 5) unlike similar complexes from vesicular stomatitis virus-infected cells (13) .
Further analysis of the RNA product and the endogenous RNA suggest that the in vitro product is associated with the in vivo RNA (Fig.  5) . Polynucleotide phosphorylase phosphorolysis shows that poly(A) is located on the 3'-OH terminus of RNA. Nearest neighbor analysis directly shows that AMP residues are polymerized on molecules which do not have 3' adenosine residues. Most poly(A) polymerase activities previously described were dependent on poly(A) or oligoriboadenylate, suggesting that they were capable of recognizing only those primers which were polyadenylated. Further demonstration that the vaccinia-induced enzyme is capable of polymerizing poly(A) on RNA which is not polyadenylated is provided by 32p transfer in the presence of added poly(U). These results (Table 3) show that poly(U) acts as a primer for poly(A) synthesis (its role as a possible template as well as a primer is uncertain).
The relation of this enzyme to the transferase described by Brown et al. (6) or the poly(A) polymerase described by Moss et al. (22) is unknown. The purified virion poly(A) polymerase (22) responds to poly(dA)-poly(dT) and poly(rC). It is unknown whether that enzyme uses a template mechanism in the first case and a primer mechanism in the second case. It has not been shown that the enzyme polymerizes poly(A) on vaccinia virus RNA. The sodium dodecyl sulfate-polyacrylamide gel electrophoretic analysis of the purified poly(A) polymerase indicated the presence of two polypeptides (22) . One of these polypeptides is enriched in the enzyme preparation described in this and the preceding report (5; C. Brakel, unpublished observations), suggesting that these enzymes may be related.
The fact that in vitro synthesized poly(A) is found on very large poly(A) fragments (see Fig.  1 and 5) is interpretable in two ways. Either the full length was synthesized in vitro on a few endogenous RNA molecules or, alternatively, very short stretches of AMP residues were polymerized on preexisting endogenous, long poly(A) molecules (see Fig. 3 ). Since most of the endogenous RNA contains poly(A) of considerable length, it is difficult to determine accurately the length of the poly(A) actually synthesized in vitro. A determination of the length of poly(A) synthesized on exogenously added poly(U) may help to clarify this point but may also lead to an erroneous interpretation since poly(U) may act not only as a primer but also as a template.
The poly(A) polymerase described here and in the preceding paper (5) is inhibited by added poly(A). Nearest neighbor analysis of the product suggests the possibility that only short lengths of poly(A) are synthesized in vitro. Since most of the endogenous RNA contains poly(A) prior to in vitro incubation, it is possible that this RNA is not the preferred primer for poly(A) synthesis. Presumably, within the cell, a fresh supply of nonpolyadenylated RNA is transcribed from the DNA and replaces the polyadenylated RNA associated with the poly(A) polymerase. The poly(A) polymerase may become less active as the poly(A) chain grows on a particular RNA. Replacement of this RNA with a nonpolyadenylated RNA would then result in poly(A) synthesis on the new RNA similar to the addition of the poly(U) to the enzyme in vitro. Since the enzyme complex lacks RNA polymerase activity, it may be less active than it might be in the presence of nonpolyadenylated RNAs. The availability of nonpolyadenylated 3'-OH termini may regulate the activity of the poly(A) polymerase. This may in turn result in the regulation of the length of the poly(A) added to RNA. Similar observations have been made with vaccinia virions by Sheldon and Kates (manuscript in preparation).
